Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Shephal Doshi

Clinical Cardiac Electrophysiology Santa Monica, CA Medical Doctor

NPI 1639176167 CMS profile 119199

2001 Santa Monica Blvd Ste 280W, Santa Monica, CA 90404

Open in the dashboard

General payments

$2,058,123

2,515 records reported · program years 2019–2025

Research payments

$13,196

Paid to them · 17 records reported · program years 2019–2025

Ownership & investment interest

$203,559

6 holdings reported · through program year 2025

Research they led as principal investigator

$871,097 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Shephal Doshi of Santa Monica, CA is reported in the CMS Open Payments database as having received $2,058,123 across 2,515 general payments and $13,196 in research payments paid to them. Separately, studies naming them as principal investigator received $871,097 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $203,559 across 6 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

14 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $443,295 420
2024 General $371,189 431
2023 General $418,447 444
2022 General $278,308 409
2021 General $223,956 322
2020 General $131,450 224
2019 General $191,479 265
2019 Research $13,196 17
2024 Ownership $27,156 1
2023 Ownership $39,735 1
2022 Ownership $34,499 1
2021 Ownership $43,161 1
2020 Ownership $30,909 1
2019 Ownership $28,099 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Shephal Doshi
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Shephal Doshi were reported at $443,295. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Shephal Doshi Clinical Cardiac Electrophysiology median Middle half National median
2019 $191,479 $2,361 $585–$8,260 $163
2020 $131,450 $993 $247–$4,351 $114
2021 $223,956 $1,185 $326–$4,739 $132
2022 $278,308 $2,073 $554–$6,789 $149
2023 $418,447 $2,568 $759–$8,159 $160
2024 $371,189 $2,557 $703–$7,403 $164
2025 $443,295 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $1,121,823 1,052 payments
  2. Medical Device Business Services, Inc. $249,317 89 payments
  3. Philips Electronics North America Corporation $246,232 121 payments
  4. Biosense Webster, Inc. $183,078 600 payments
  5. Abbott Laboratories $112,513 202 payments
  6. Galvanize Therapeutics, Inc $39,053 26 payments
  7. Novo Nordisk AS $36,536 7 payments
  8. Janssen Pharmaceuticals, Inc $21,326 37 payments
  9. Siemens Medical Solutions USA, Inc. $15,411 29 payments
  10. Medtronic, Inc. $6,402 160 payments
  11. Other $26,432 192 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $876,960 310 payments
  2. Consulting Fee $865,373 272 payments
  3. Travel and Lodging $164,530 393 payments
  4. Food and Beverage $72,781 1,525 payments
  5. Acquisitions $36,791 1 payment
  6. Grant $24,550 6 payments
  7. Honoraria $7,900 2 payments
  8. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $6,975 3 payments
  9. Compensation for serving as faculty or as a speaker for a medical education program $2,250 2 payments
  10. Education $13 1 payment
Products named General payments · program years 2019–2025
  1. WATCHMAN Access System $315,619 257 payments
  2. Carto 3 $294,123 452 payments
  3. (9520) IGT Devices Undivided $209,339 55 payments
  4. WATCHMAN Structural Heart $198,272 173 payments
  5. FARAPULSE $110,667 108 payments
  6. WATCHMAN FLX $92,441 93 payments
  7. WATCHMAN Pain Management $73,529 36 payments
  8. Carto 3 System $50,867 72 payments
  9. General - EP $48,004 38 payments
  10. WATCHMAN Structural Heart $39,460 45 payments
  11. Other $404,171 989 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. MicroVention, Inc. $13,196 17 payments

Prescribing to Medicare patients

Part D · data year 2024 · 34 drugs

Part D claims

1,704

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$476,191

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

39.6%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 235 $247,708
Xarelto Rivaroxaban Brand 116 $126,597
Repatha Sureclick Evolocumab Brand 54 $46,941
Jardiance Empagliflozin Brand 24 $20,523
Praluent Pen Alirocumab Brand 13 $8,018
Colchicine Generic 99 $4,211
Metoprolol Succinate Generic 206 $3,330
Flecainide Acetate Generic 55 $2,433
Nebivolol Hcl Generic 14 $1,763
Rosuvastatin Calcium Generic 68 $1,615

The 10 drugs with the highest cost, of 34 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 65 billing codes

Paid by Medicare

$390,919

Medicare's payments for the services billed

Medicare patients

685

Average age 78

Services billed

3,244

275 women, 410 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 75%
Ischemic heart disease 58%
Arthritis 54%
Heart failure 36%
Diabetes 30%
Chronic kidney disease 24%
Cancer 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 8 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XARELTO
$48 116 —
CAMZYOS
$21 — —
Arcalyst
$20 — —
MULTAQ
$16 — —
AMVUTTRA
$15 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 8 in the dashboard with a free account

Records

2,532 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record